🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary hypothesis is that cancer vaccine can convert non-immunogenic g...
Status
Unknown
Location
National University Hospital
Start Date
2019-02-21
Trial ID
NCT03784040
Treatments Being Tested
This study is looking at outcomes in people with advanced cancers who have ...
Status
Terminated
Location
Peter MacCallum Cancer Centre
Start Date
2021-09-23
Trial ID
NCT04801966
Background: Gastrointestinal cancer is one of the most common cancers worl...
Status
Terminated
Location
National Institutes of Health Clinical Center
Start Date
2020-08-09
Trial ID
NCT04166383
Treatments Being Tested
This is a multi-center Phase II randomized study. We plan to enroll 78 pati...
Status
Terminated
Location
City of Hope
Start Date
2018-06-26
Trial ID
NCT03547999
Treatments Being Tested
Primary Objectives: 1. To determine the maximum tolerated dose (MTD) or ma...
Status
Terminated
Location
UC San Diego Moores Cancer Center
Start Date
2017-03-27
Trial ID
NCT03059147
The purpose of this study is to test the safety and tolerability of the res...
Status
Completed
Location
Saint John's Cancer Institute
Start Date
2018-03-01
Trial ID
NCT03425292
The goal of this clinical research study is to determine whether the PD-1 i...
Status
Active Not Recruiting
Location
University of Colorado Anschutz Medical Campus
Start Date
2019-01-30
Trial ID
NCT03347838
Treatments Being Tested
Nivolumab releases the inhibition of the immune system against human cancer...
Status
Terminated
Location
Rhode Island Hospital
Start Date
2016-02
Trial ID
NCT02469701
Treatments Being Tested
This is a Phase 2 study designed to evaluate the combination of checkpoint ...
Status
Completed
Location
University of Minnesota Masonic Cancer Center
Start Date
2019-05-28
Trial ID
NCT03850691
Melanoma remains a common cancer with rising incidence, and despite signifi...
Status
Not Yet Recruiting
Location
HFR Fribourg
Start Date
2026-09
Trial ID
NCT07574047
Treatments Being Tested